After the Autumn 2025 budget was announced by Chancellor of the Exchequer Rachel Reeves, Med-Tech Insights reached out to contacts in the industry for comment on what it would mean for the healthcare space, as well as being inundated with comments from the wider life sciences sector. Mark Leftwich,
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, and advisor to MedTech suppliers, reports on recent developments at NHS Supply Chain and their potential implications for suppliers, the NHS, patients, and the wider MedTech
Brian Mangan, formerly of NHS Supply Chain and now CEO of Luach Consulting Group sat down with the Medical Technology Group to discuss the NHS’s new value based procurement guidelines How did you come to be involved with value based procurement? NHS Supply Chain said they had a lot of industry comin
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, and advisor to MedTech suppliers, promotes calls to put patient safety at the heart of AI MedTech regulation. The Patient Safety Commissioner, Professor Henrietta Hughes, has
Innovation and product development in the MedTech and life sciences industry is high risk, with many products failing in the marketplace. Therefore, in order to de-risk and accelerate product development it is important to have strategies and processes in place that ensure the innovation is addressi
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, and advisor to MedTech suppliers, reports on the focus NHS England is placing on promoting the NHS App as the go-to digital contact point for healthcare in England. The NHS A
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, and advisor to MedTech suppliers, focuses on the MHRA’s programme for the development and adoption of new AI MedTech. In a significant step toward embedding artificial intell
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, and advisor to MedTech suppliers, highlights new resources allocated to NHS Supply Chain and warns of the dangers of its strategic shift to dominate non-acute supply of MedTe
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, and advisor to MedTech suppliers, reports on a new initiative from the Department of Health and Social Care (DHSC) to develop national guidance for local formularies covering
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, and an advisor to MedTech suppliers, calls on the sector to “wake up and smell the coffee” as new guidance is issued on value based procurement. The UK Government’s Departmen
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, and advisor to MedTech companies highlights the short deadline for submission of evidence to a parliamentary committee looking into barriers to MedTech innovation and adoptio
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, and advisor to MedTech suppliers welcomes substantial investment in vaccine production. The UK government has unveiled plans for a new vaccine manufacturing facility in Oxfor
